You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MRD results

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, MRD Trial in Shanghai (Azacitidine, Venetoclax, Selinexor)

Not yet recruiting
  • AML
  • MRD
  • Shanghai, China
  • +3 more
Feb 12, 2023

Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ

Recruiting
  • Acute Lymphoblastic Leukemia, Adult B-Cell
  • +3 more
  • clonoSEQ Assay
  • Stanford, California
  • +15 more
Jan 30, 2023

Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

Not yet recruiting
  • Minimal Residual Disease
  • Esophageal Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Jun 10, 2023

    s Recurrence and Response Via a Tumor Informed Assessment

    Recruiting
    • Cancer
    • +4 more
    • Personalized Cancer Monitoring (PCM)
    • San Francisco, California
    • +1 more
    Dec 5, 2022

    MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)

    Recruiting
    • Myelodysplastic Syndromes
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 18, 2023

    Mobility Limitation, Overweight or Obesity, Physical Disability Trial in Lawrence (Functional Fitness)

    Recruiting
    • Mobility Limitation
    • +2 more
    • Functional Fitness
    • Lawrence, Kansas
      University of Kansas
    May 26, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Different induction chemotherapy regimens
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Sep 27, 2023

    ALL, Childhood B-Cell, Acute Lymphoid Leukemia Relapse, Acute Lymphocytic Leukemia Refractory Trial (Tafasitamab)

    Not yet recruiting
    • ALL, Childhood B-Cell
    • +2 more
    • Tafasitamab
    • (no location specified)
    Nov 25, 2022

    Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Trial (Monalizumab, Cetuximab)

    Not yet recruiting
    • Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
    • Monalizumab
    • Cetuximab
    • (no location specified)
    Jan 8, 2023

    Mantle Cell Lymphoma (MCL) Trial in Australia, Canada, United States (Acalabrutinib, Venetoclax, Rituximab)

    Not yet recruiting
    • Mantle Cell Lymphoma (MCL)
    • Duarte, California
    • +11 more
    Jul 17, 2023

    Clinical Research of Drug Holiday Based on MRD Detection in GIST

    Recruiting
    • Gastrointestinal Stromal Tumors
      • Beijing, Beijing, China
        Peking University People's Hospital
      May 11, 2023

      Clinical Pathways for Newly Diagnosed Multiple Myeloma

      Not yet recruiting
      • Multiple Myeloma
      • Multiple Myeloma Without Mention of Remission
      • Multiple Myeloma Pathway
      • +2 more
      • (no location specified)
      Nov 27, 2023

      Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

      Not yet recruiting
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • Zanubrutinib Pill
      • +2 more
      • New York, New York
        Weill Cornell Medicine/NewYork-Presberteryian Hospital
      Dec 6, 2022

      ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • NGS and ctDNA-MRD detection
      • Changsha, Hunan, China
        Department of Thoracic Surgery, Second Xiangya Hospital of Centr
      Apr 18, 2023

      High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

      Not yet recruiting
      • High-Risk de Novo Multiple Myeloma
      • Badalona, Spain
      • +9 more
      Apr 27, 2023

      HER2-positive Breast Cancer Trial in Chuo-ku

      Recruiting
      • HER2-positive Breast Cancer
        • Chuo-ku, Tokyo, Japan
          National Cancer Center Hospital, Japan
        Jun 22, 2022

        Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

        Recruiting
        • Leukemia, Myeloid, Acute
        • Jerusalem, Yerushalayim, Israel
          Shaare Zedek Medical Center
        Oct 25, 2022

        Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

        Recruiting
        • Leukemia, Myeloid, Acute
        • Minimal Residual Disease
          • Chapel Hill, North Carolina
            North Carolina Cancer Hospital (NCCH)
          Feb 2, 2023

          MRD Trial in China (Adjuvant treatment for MRD positivity)

          Recruiting
          • MRD
          • Adjuvant treatment for MRD positivity
          • Beijing, China
          • +15 more
          Sep 12, 2022

          Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

          Recruiting
          • Gastrointestinal Stromal Tumors
          • Minimal Residual Disease
          • liquid biopsy
          • Beijing, Beijing, China
            Peking University People'S Hospital
          Sep 18, 2022

          Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Memphis, Tennessee
            St. Jude Children's Research Hospital
          Jul 21, 2023

          ALL, Recurrent, Adult Trial in Germany (Blinatumomab)

          Active, not recruiting
          • ALL, Recurrent, Adult
          • Frankfurt (Main), Hessen, Germany
          • +21 more
          Mar 16, 2022

          T-cell Acute Lymphoblastic Leukemia Trial in Chicago (Daratumumab / Hyaluronidase Injection)

          Recruiting
          • T-cell Acute Lymphoblastic Leukemia
          • Daratumumab / Hyaluronidase Injection
          • Chicago, Illinois
            Northwestern
          Jun 17, 2022

          MRD Application in Colorectal Cancer Patients

          Recruiting
          • Colorectal Cancer
          • +2 more
            • Jinan, Shandong, China
              Jinan central hospital affiliated to Shandong First Medical Univ
            Sep 1, 2023

            Follicular Non-Hodgkin's Lymphoma Trial in Italy (R-CHOP or R-bendamustine, Observation, Maintenance weekly x4)

            Active, not recruiting
            • Follicular Non-Hodgkin's Lymphoma
            • R-CHOP or R-bendamustine
            • +4 more
            • Meldola, Forlì Cesena, Italy
            • +47 more
            Dec 29, 2021